fbpx

Health Care

Congress restores $85M to FDA program for reviewing new drugs

Restoration of that money means the FDA can resume using the targeted fees toward advancing its drug and medical device review program. “The release of these funds will benefit patients, public health and medical innovation,” said Lance, R-Westfield, who lobbied for restoring the fees to the FDA’s budget and introduced a bill last year to ...

Read More »

Merck seeks federal approval for experimental melanoma drug

The submission is a big priority for the Hunterdon County pharmaceutical company as it seeks to replenish its pipeline after several patent expirations on blockbuster drugs. The drug, MK-3475, is part of a class of drugs known as anti-PD-1 immunotherapies, which treat cancer by stimulating the body’s immune system. Merck is doing so via a ...

Read More »

Drugs for little-known symptoms can bring big-time profits

Take the Princeton-based Advaxis Inc., which developed its lead drug candidate, ADXS-HPV, to treat various forms of cancer associated with human papillomavirus. ADXS-HPV has received orphan drug designation for the product’s application to anal cancer, as well as head and neck cancer. Advaxis is also seeking orphan drug status for invasive cervical cancer. Add them ...

Read More »

Princeton’s Advaxis feels building solutions for multiple cancer types is a key to finding a cure

Women suffering from breast cancer. The two diseases may appear unrelated, but the Princeton-based biotech company Advaxis Inc. is eager to exploit the connection: Dogs with bone cancer express the same antigen — a harmful substance that causes the body to produce antibodies — as women with certain forms of breast cancer. Encouraging data with ...

Read More »

CommVault anchoring Fort Monmouth project

The Oceanport-based software company is inching closer to opening its new Tinton Falls location, a 55-acre campus that will house headquarters about triple the size of its current home. The transition, expected to begin later this year, can’t start soon enough for CommVault, which executives say is bursting out of its existing Crescent Place facility. ...

Read More »

Empowered to fight

The newfound optimism stems from clinical results showing improved survival rates among patients receiving immunotherapy, fueling hope that cancer can become more manageable and less of a death sentence. That someday there could be a cure. “It is the hottest area of cancer research today,” said Daniel O’Connor, the CEO of Advaxis, a company we ...

Read More »

Quest Diagnostics to form research partnership with UC San Francisco

Initial areas will focus on autism, oncology, neurology and women’s wealth, according to a news release from both organizations. They say the idea is to combine the academic expertise of UCSF with Quest’s national testing database and clinical resources. Scientists from both organizations will conduct joint research and develop products focused on improving precision medicine, ...

Read More »

Amneal Pharmaceuticals appoints new CFO

According to the announcement, Fuhrmann was most recently senior vice president for finance at Warner Chilcott plc. She was responsible for the oversight and direction of the finance and accounting functions including corporate accounting, financial planning and analysis, tax, treasury, risk management, and internal audit as well as investor relations. Stay informed: Subscribe to free ...

Read More »

Forest Laboratories acquires Aptalis for $2.9B

Forest Laboratories will acquire Aptalis from its private equity owner, TPG, pending required reviews by antitrust authorities. The deal is expected to close in the first half of 2014. Aptalis CEO Frank Verweil said in a statement that the company has grown under TPG’s ownership though internal product development and acquisitions, “and now our new, ...

Read More »

Pappajohn named new chairman of Cancer Genetics

Cancer Genetics said Pappajohn has been involved with more than 100 start-up companies, 50 initial public offerings, and served as a director for more than 40 public companies, many in bioscience and health-related industries.“My personal goal for CGI is to help the company become the world leader in DNA-based diagnostics,” Pappajohn, a shareholder of Cancer ...

Read More »